TITLE

Lycopene in the Prevention of Prostate Cancer

AUTHOR(S)
Dahan, Karen; Fennal, Mildred; Kumar, Nagi B.
PUB. DATE
January 2008
SOURCE
Journal of the Society for Integrative Oncology;Winter2008, Vol. 6 Issue 1, p29
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Based on the evidence from epidemiologic, animal, and in vitro data and human clinical trials, it is evident that lycopene, a nonprovitamin A carotenoid, is a promising agent for prostate cancer chemoprevention. It is also clear that the form of lycopene used (purified versus food sources), dose of lycopene and concomitant use with other carotenoids and antloxidants, duration of exposure, specific target populations, and stage of disease appear to play a major role in determining agonistic or antagonistic effects. Based on our review, there is enough evidence to warrant use of lycopene in phase I and II clinical trials to examine its safety and efficacy as a potential chemopreventive agent for prostate cancer. The objective of this article is to review this evidence from epidemiologic, animal, in vitro, and clinical trials and provide the need and rationale to examine further the role of lycopene for prostate cancer prevention.
ACCESSION #
31504285

 

Related Articles

  • Carotenoids and Prostate Cancer Risk. Young, C. Y. F.; Yuan, H.-Q.; He, M.-L.; Zhang, J.-Y. // Mini Reviews in Medicinal Chemistry;May2008, Vol. 8 Issue 5, p529 

    Chemoprevention is presumably one of most effective means to combat prostate cancer (PCa). Patients usually require more than a decade to develop a clinically significant Pca, therefore, an ideal target for chemoprevention. This review will focus on recent findings of a group of naturally...

  • High Lycopene Level Reduces Risk of Advanced Prostate Cancer. Kiefer, Dale // Life Extension;Jan2008, Vol. 14 Issue 1, p18 

    The article discusses a new published study from Europe which shows the 60% risk reduction of men with high lycopene level to develop advanced form of prostate cancer. The study which used more than 137,000 men from eight countries in the continent assessed 1,000 subjects who developed prostrate...

  • The relationship between dietary carotenoids and prostate cancer risk in Southeast Chinese men. Binns, C. W.; Jian, L.; Lee, A. H. // Asia Pacific Journal of Clinical Nutrition;2004 Supplement, Vol. 13, pS117 

    To investigate whether dietary intake of lycopene and other carotenoids has an aetiological association with prostate cancer, a case-control study was conducted in Hangzhou, southeast China during 2001-2002. The cases were 130 incident patients with histologically confirmed adenocarcinoma of the...

  • Seeing Red. Schoenhals, Kim // Better Nutrition;Jun2005, Vol. 67 Issue 6, p32 

    This article focuses on the importance of lycopene, a member of carotenoid family, present in fruits and vegetables like tomatoes, watermelon, pink grapefruit and guava. Research indicates that lycopene supplements and lycopene-rich foods such as tomato sauce may support fertility promote...

  • Serum Lycopene, Other Serum Carotenoids, and Risk of Prostate Cancer in US Blacks and Whites. Vogt, T. M.; Mayne, S. T.; Graubard, B. I.; Swanson, C. A.; Sowell, A. L.; Schoenberg, J. B.; Swanson, G. M.; Greenberg, R. S.; Hoover, R. N.; Hayes, R. B.; Ziegler, R. G. // American Journal of Epidemiology;Jun2002, Vol. 155 Issue 11, p1023 

    Epidemiologic studies investigating the relation between individual carotenoids and risk of prostate cancer have produced inconsistent results. To further explore these associations and to search for reasons prostate cancer incidence is over 50% higher in US Blacks than Whites, the authors...

  • medical miracles. Haire, Pat // Sarasota Magazine;May2001, Vol. 23 Issue 8, p122 

    Focuses on medical breakthroughs in southwest Florida. Clinical trial by doctor Keye Wong at the Sarasota Retina Institute; Type of surgery called deep brain stimulation; Role of lycopene in preventing prostate cancer.

  • How to use PCa prevalence data to guide chemoprevention. Haas, Gabriel R. // Urology Times;12/1/2005, Vol. 33 Issue 15, p28 

    This article discusses the impact of the prevalence of prostate cancer on chemoprevention, and provides guidance when patients ask about their likelihood of being diagnosed and their ability to prevent it. Carcinogenesis is a complex transformation from benign to malignant tissue pathology....

  • Strategies for prostate cancer prevention: Review of the literature. Moorthy, H. Krishna; Venugopal, P. // Indian Journal of Urology;Jul-Sep2008, Vol. 24 Issue 3, p295 

    The goal of primary chemoprevention is to decrease the incidence of a given cancer, simultaneously reducing treatment-related adverse events, cost of treatment of the disease and mortality. Prostate cancer is an attractive and appropriate target for primary prevention because of its high...

  • Chemoprevention of prostate cancer: an updated view. Klein, Eric; Thompson, Ian // World Journal of Urology;Apr2012, Vol. 30 Issue 2, p189 

    Objectives: To place chemoprevention of prostate cancer in current clinical context. Methods: Review of recently published updates of large, randomized, controlled trials of primary chemoprevention of prostate cancer. Results: With extended post-intervention follow-up, SELECT demonstrated a 17%...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics